FluBHPVE6E7

N/A

Report date: 2026/02/26 20:00:22

Base Information

Drug NameFluBHPVE6E7
Drug Alias NameFluBHPVE6E7delNS/E6E7delNS106delNS106/E6E7Flu-BHPV-E6E7
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsOropharyngeal Squamous Cell Carcinoma (OPSCC)Uterine Cervical NeoplasmsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySlovakiaAustria
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBlueSky Immunotherapies GmbH
China Registration ClassN/A

Develop Information

Active CompaniesBlueSky Immunotherapies GmbH
Inactive CompaniesN/A
Active IndicationsOropharyngeal Squamous Cell Carcinoma (OPSCC)Uterine Cervical NeoplasmsPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A